and TF+ (C) MP counts than healthy controls (HC). MP were enumerated in non-smoking BS versus HC plasma by flow cytometry using annexin V and mAb against CD14 and TF. ***p< 0.001.
Supplementary Figure 3: Correlation of total (A), CD14+ (B), TF+ (C)
and CD14/TF+ (D) MP counts in BS patient with age. There was no statistically significant correlation found.
Supplementary Figure 4:
The total (A), CD14+ (B) and TF+ (C) MP counts in Behçet's Syndrome (BS) patients taking prednisolone (BS + Pred) are not significantly different from those in BS patients not taking prednisolone BS -Pred). MP were enumerated by flow cytometry using annexin V and mAb against CD14 and TF. NS = not significant.
